GASTRIC-MUCOSAL PROTECTION BY YM638, A NOVEL LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN RATS

被引:2
|
作者
MIYATA, K
KAMATO, T
NISHIDA, A
TAKIZAWA, K
TAKEDA, M
机构
[1] Institute for Drug Discovery Research, Yamanouchi Pharmaceutical Co. Ltd., Tsukuba, Ibaraki, 305
关键词
YM638 ([[5-[[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PROPYL]THIO]-1,3,4-THIADIAZOL-2-YL]THIO] ACETIC ACID); LEUKOTRIENE D-4 RECEPTOR ANTAGONIST; GASTRIC MUCOSAL PROTECTION; GASTRIC LESION;
D O I
10.1016/0014-2999(95)00035-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
YM638 ([[5-[[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propyl]thio]-1,3,4-thiadiazol-2-yl]thio] acetic acid) is a novel leukotriene D-4 receptor antagonist. We investigated the involvement of the leukotriene D-4 receptor blocking activity of YM638 in the gastric mucosal protection of this drug in rats. YM638 significantly prevented gastric lesion formation induced by water-immersion restraint stress, indomethacin, absolute ethanol, 0.7 N HCl and the combination of 0.2 N HCl and hemorrhagic shock, with ED(50) values of 26.4, 4.1, 4.7, 35.4 and 8.0 mg/kg p.o., respectively. Cetraxate and sofalcone showed inhibitory effects on most of these gastric lesions, but the inhibitory effects of these compounds were much weaker than those of YM638. In contrast, YM638 had no effect on gastric acid secretion and gastric lesion formation in pylorus-ligated rats, or on duodenal lesion formation in cysteamine-administered rats. YM638 competitively antagonized leukotriene D-4-induced contraction of the isolated stomach, with a pA(2) value of 7.63 +/- 0.18. In anesthetized rats, intravenous YM638 inhibited leukotriene D-4-induced aggravation of gastric lesions caused by HCl, and leukotriene D-4 and HCl-induced reduction of the potential difference. In addition, oral YM638 significantly increased gastric mucosal blood flow and prevented ethanol-induced increase in gastric vascular permeability. Endogenous prostaglandins, sulfhydryls and nitric oxides were not involved in this inhibitory effect on absolute ethanol-induced gastric lesion, YM638 did not react with the stable free radical 1,1-diphenyl-2-picrylhydrazyl in vitro, indicating that YM638 does not have potential as free radical scavenger. These results suggest that the preventive effect of YM638 on gastric lesions is attributable not only to its leukotriene D-4 receptor blocking activity but also to the activation of gastric mucosal defensive mechanisms such as mucosal blood flow and vascular permeability.
引用
收藏
页码:165 / 175
页数:11
相关论文
共 47 条
  • [21] LU 111995: A Novel D-4/5-HT2 receptor antagonist and potential new antipsychotic.
    Steiner, G
    Bach, A
    Bialojan, S
    Greger, G
    Hoger, T
    Klebe, G
    Munschauer, R
    Teschendorf, HJ
    Traut, M
    Unger, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 213 : 186 - MEDI
  • [22] EVOLUTION OF A SERIES OF NON-QUINOLINE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST - SYNTHESIS AND SAR OF BENZOTHIAZOLES AND THIAZOLES SUBSTITUTED BENZYL ALCOHOLS AS POTENT LTD(4) ANTAGONISTS
    LAU, CK
    DUFRESNE, C
    GAREAU, Y
    ZAMBONI, R
    LABELLE, M
    YOUNG, RN
    METTERS, KM
    ROCHETTE, C
    SAWYER, N
    SLIPETZ, DM
    CHARETTE, L
    JONES, T
    MCAULIFFE, M
    MCFARLANE, C
    FORDHUTCHINSON, AW
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (15) : 1615 - 1620
  • [23] EFFECTS OF 6 WEEKS OF THERAPY WITH ORAL DOSES OF ICI-204,219, A LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, IN SUBJECTS WITH BRONCHIAL-ASTHMA
    SPECTOR, SL
    SMITH, LJ
    GLASS, M
    BIRMINGHAM, BK
    BRONSKY, EA
    DUNN, KD
    FISH, JE
    GROSSMAN, J
    HOWLAND, W
    MINKWITZ, MC
    LARSEN, JS
    NATHAN, RA
    RENNARD, SI
    SCHULMAN, ES
    SEGAL, A
    SELTZER, LM
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (03) : 618 - 623
  • [24] Persistent airway eosinophilia after leukotriene (LT) D-4 administration in the guinea pig - Modulation by the LTD(4) receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody
    Underwood, DC
    Osborn, RR
    Newsholme, SJ
    Torphy, TJ
    Hay, DWP
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) : 850 - 857
  • [25] EFFECT OF A NOVEL AND POTENT CCK-B RECEPTOR ANTAGONIST, YM022, ON GASTRIC AND PANCREATIC-SECRETION IN-VIVO IN RATS
    SHIRATORI, K
    WATANABE, S
    SHIMIZU, K
    MORIYOSHI, Y
    TAKEUCHI, T
    GASTROENTEROLOGY, 1995, 108 (04) : A218 - A218
  • [26] NGD 94-1: Identification of a novel, high-affinity antagonist at the human dopamine D-4 receptor .1.
    Tallman, JF
    Primus, RJ
    Brodbeck, R
    Cornfield, L
    Meade, R
    Woodruff, K
    Ross, P
    Thurkauf, A
    Gallager, DW
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 282 (02): : 1011 - 1019
  • [27] EFFECT OF MK-571, A SELECTIVE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, ON VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND INTERLEUKIN-1 RELEASE
    PORRECA, E
    REALE, M
    DIFEBBO, C
    BARBACANE, RC
    CASTELLANI, ML
    CIPOLLONE, F
    CARRATELLI, L
    CONTI, P
    CUCCURULLO, F
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1994, 7 (01) : 57 - 64
  • [28] SPECIFIC ALPHA-2-ANTAGONIST REDUCES INTRAGASTRIC NICOTINE-MEDIATED PROTECTION AGAINST 40-PERCENT ETHANOL-INDUCED GASTRIC-MUCOSAL INJURY IN RATS
    ENDOH, K
    BAKER, M
    LEUNG, FW
    CLINICAL RESEARCH, 1991, 39 (01): : A94 - A94
  • [29] DETERMINATION OF BAYX7195, A NOVEL LEUKOTRIENE D-4 ANTAGONIST, IN HUMAN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH POSTCOLUMN PHOTO DERIVATIZATION AND FLUORESCENCE DETECTION
    HEINIG, R
    JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 667 (01): : 137 - 147
  • [30] L-648,051, SODIUM 4-[3-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)-PROPYLSULFONYL] GAMMA-OXO-BENZENEBUTANOATE - A LEUKOTRIENE D-4 RECEPTOR ANTAGONIST
    JONES, TR
    GUINDON, Y
    YOUNG, R
    CHAMPION, E
    CHARETTE, L
    DENIS, D
    ETHIER, D
    HAMEL, R
    FORDHUTCHINSON, AW
    FORTIN, R
    LETTS, G
    MASSON, P
    MCFARLANE, C
    PIECHUTA, H
    ROKACH, J
    YOAKIM, C
    DEHAVEN, RN
    MAYCOCK, A
    PONG, SS
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1986, 64 (12) : 1535 - 1542